In addition, recent studies on using circadian rhythm signatures to predict survival and immunotherapy effects in specific tumor types [16–18], as well as studies on the association between circadian clock gene expression and tumor immunity and patient prognosis in specific tumors [19–21]. This evidence concerns the gene CLOCK and neoplasm.